Natural product-inspired esters and amides of ferulic and caffeic acid as dual inhibitors of HIV-1 reverse transcriptase

被引:43
|
作者
Sonar, Vijay P. [1 ]
Corona, Angela [2 ]
Distinto, Simona [1 ]
Maccioni, Elias [1 ]
Meleddu, Rita [1 ]
Fois, Benedetta [1 ]
Floris, Costantino [3 ]
Malpure, Nilesh V. [4 ]
Alcaro, Stefano [5 ]
Tramontano, Enzo [2 ]
Cottiglia, Filippo [1 ]
机构
[1] Univ Cagliari, Drug Sci Sect, Dept Life & Environm Sci, Via Osped 72, I-09124 Cagliari, Italy
[2] Univ Cagliari, Dept Life & Environm Sci, Cittadella Monserrato SS554, I-09042 Cagliari, Italy
[3] Univ Cagliari, Dipartimento Sci Chim, I-09042 Cagliari, Italy
[4] SSGM Coll, Dept Bot, IN-423601 Kopargaon, MS, India
[5] Magna Graecia Univ Catanzaro, Dipartimento Sci Salute, Campus S Venuta,Viale Europa, I-88100 Catanzaro, Italy
关键词
Ocimum sanctum; HIV-1; RNase H; Reverse transcriptase; Triterpenes; Ferulic acid derivatives; RIBONUCLEASE H ACTIVITY; MOLECULAR-MECHANICS; BINDING-AFFINITY; ACTIVE-SITE; RNASE-H; DERIVATIVES; IDENTIFICATION; PARAMETERS; RECEPTORS; DISCOVERY;
D O I
10.1016/j.ejmech.2017.02.054
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Using an HIV-1 Reverse Transcriptase (RT)-associated RNase H inhibition assay as lead, bioguided fractionation of the dichloromethane extract of the Ocimum sanctum leaves led to the isolation of five triterpenes (1-5) along with three 3-methoxy-4-hydroxy phenyl derivatives (6-8). The structure of this isolates were determined by 1D and 2D NMR experiments as well as ESI-MS. Tetradecyl ferulate (8) showed an interesting RNase H IC50 value of 12.4 mu M and due to the synthetic accessibility of this secondary metabolite, a structure-activity relationship study was carried out. A series of esters and amides of ferulic and caffeic acids were synthesized and, among all, the most active was N-oleylcaffeamide displaying a strong inhibitory activity towards both RT-associated functions, ribonuclease H and DNA polymerase. Molecular modeling studies together with Yonetani-Theorell analysis, demonstrated that Noleylcaffeamide is able to bind both two allosteric site located one close to the NNRTI binding pocket and the other close to RNase H catalytic site. (C) 2017 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:248 / 260
页数:13
相关论文
共 50 条
  • [1] HIV-1 reverse transcriptase inhibitors
    El Safadi, Yazan
    Vivet-Boudou, Valerie
    Marquet, Roland
    APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2007, 75 (04) : 723 - 737
  • [2] HIV-1 reverse transcriptase inhibitors
    Lloyd, AW
    DRUG DISCOVERY TODAY, 1996, 1 (03) : 122 - 122
  • [3] HIV-1 reverse transcriptase inhibitors
    Yazan El Safadi
    Valérie Vivet-Boudou
    Roland Marquet
    Applied Microbiology and Biotechnology, 2007, 75 : 723 - 737
  • [4] Isatin thiazoline hybrids as dual inhibitors of HIV-1 reverse transcriptase
    Meleddu, Rita
    Distinto, Simona
    Corona, Angela
    Tramontano, Enzo
    Bianco, Giulia
    Melis, Claudia
    Cottiglia, Filippo
    Maccioni, Elias
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2017, 32 (01) : 130 - 136
  • [5] Fullerene derivatives as dual inhibitors of HIV-1 reverse transcriptase and protease
    Yasuno, Takumi
    Ohe, Tomoyuki
    Kataoka, Hiroki
    Hashimoto, Kosho
    Ishikawa, Yumiko
    Furukawa, Keigo
    Tateishi, Yasuhiro
    Kobayashi, Toi
    Takahashi, Kyoko
    Nakamura, Shigeo
    Mashino, Tadahiko
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2021, 31
  • [6] Novel HIV-1 reverse transcriptase inhibitors
    Jochmans, Dirk
    VIRUS RESEARCH, 2008, 134 (1-2) : 171 - 185
  • [7] An overview on HIV-1 reverse transcriptase inhibitors
    Ravichandran, Shalini
    Veerasamy, Ravichandran
    Raman, Saraswathi
    Krishnan, Palamadai Neelakandam
    Agrawal, Ram Kishore
    DIGEST JOURNAL OF NANOMATERIALS AND BIOSTRUCTURES, 2008, 3 (04) : 171 - 187
  • [8] Advances in rationally designed dual inhibitors of HIV-1 reverse transcriptase and integrase
    Gu, Shuang-Xi
    Xue, Ping
    Ju, Xiu-Lian
    Zhu, Yuan-Yuan
    BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (21) : 5007 - 5016
  • [9] Inhibitors from Natural Products to HIV-1 Reverse Transcriptase, Protease and Integrase
    Jiang, Y.
    Ng, T. B.
    Wang, C. R.
    Zhang, D.
    Cheng, Z. H.
    Liu, Z. K.
    Qiao, W. T.
    Geng, Y. Q.
    Li, N.
    Liu, F.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2010, 10 (14) : 1331 - 1344
  • [10] Emerging reverse transcriptase inhibitors for HIV-1 infection
    Rai, Mohammad A.
    Pannek, Sam
    Fichtenbaum, Carl J.
    EXPERT OPINION ON EMERGING DRUGS, 2018, 23 (02) : 149 - 157